Dr. Jeremy Grimshaw a world leader in knowledge translation and implementation science, a rapidly emerging field with substantial impact on health services and policy research. He has devoted his career to bridging the gap between research and clinical care; by encouraging health care professionals to adopt evidence-based research, new research discoveries can be converted into improved population health and efficient health care delivery. His research explores determinants of professional and health-care system performance, evaluates dissemination and implementation strategies to improve care, and builds theoretical and methodological developments. He is a full professor in the Department of Medicine and is also cross-appointed to the School of Epidemiology and Public Health; he is a senior scientist in the Clinical Epidemiology Program at the Ottawa Hospital Research Institute and a Tier 1 Canada Research Chair in Health Knowledge Transfer and Uptake. He is a member of the Canadian Network on Hepatitis C.

Melinda is the Clinical Nurse Lead at the Australasian Society of HIV, Viral Hepatitis and Sexual Health Medicine. Melinda’s primary focus is identifying opportunities to advance the role of nurses providing BBV and sexual health care through collaboration, education and identification of policy issues to support knowledge translation and implementation of care within our healthcare system. Melinda is a Registered Nurse, a Fellow of the Australian College of Nursing, Australasian Hepatology Association Board Secretary, holds a Graduate Certificate in Health Promotion and a Masters degree in Public Health.

Alison Marshall is a postdoctoral fellow with an academic background in epidemiology and social research. Her primary research interests involve increasing access to hepatitis C care for people who inject drugs.

Jennifer MacLachlan is the senior epidemiologist for the WHO Collaborating Centre for Viral Hepatitis at The Doherty Institute, and currently leads the National Viral Hepatitis Mapping Project. Her work focuses on the innovative use of routinely collected data to assess progress in Australia’s strategic response to viral hepatitis.